Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor Pembrolizumab

Recent developments in immune checkpoint inhibitors (ICIs) have provided new treatment strategies for advanced cancer. However, ICIs lead to an imbalance between T cell–mediated inflammatory responses and immune tolerance in the myocardium. Here we report the first case that implicates the contribut...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JACC Case Rep
Prif Awduron: Oishi, Hideo, Morimoto, Ryota, Shimoyama, Yoshie, Kuroda, Kei, Urata, Toru, Kondo, Toru, Okumura, Takahiro, Bando, Yasuko K., Akiyama, Masashi, Murohara, Toyoaki
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2020
Pynciau:
Mini-Focus Issue: Cardiomyopathies
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8299122/
https://ncbi.nlm.nih.gov/pubmed/34317084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2020.07.028
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg